In vitro multispecies Lubbock chronic wound biofilm model.
about
Chronic Wound Biofilm ModelAn in vivo polymicrobial biofilm wound infection model to study interspecies interactionsEvaluation of the bacterial diversity of pressure ulcers using bTEFAP pyrosequencing.Comparative analysis of single-species and polybacterial wound biofilms using a quantitative, in vivo, rabbit ear model.Biofilms and persistent wound infections in United States military trauma patients: a case-control analysisGlycoside Hydrolases Degrade Polymicrobial Bacterial Biofilms in WoundsSynergistic interactions of Pseudomonas aeruginosa and Staphylococcus aureus in an in vitro wound model.Quorum sensing inhibitors increase the susceptibility of bacterial biofilms to antibiotics in vitro and in vivo.Polymicrobial interactions: impact on pathogenesis and human disease.Vancomycin and maltodextrin affect structure and activity of Staphylococcus aureus biofilms.Biofilm models of polymicrobial infection.Comparison of culture and molecular identification of bacteria in chronic wounds.The Human Cathelicidin Antimicrobial Peptide LL-37 as a Potential Treatment for Polymicrobial Infected WoundsA rapid molecular method for characterising bacterial bioburden in chronic wounds.Regular debridement is the main tool for maintaining a healthy wound bed in most chronic wounds.A review of the scientific evidence for biofilms in wounds.Biofilms in wounds: a review of present knowledge.Approach to chronic wound infections.Chronic Wound Biofilms: Pathogenesis and Potential Therapies.Co-infecting microorganisms dramatically alter pathogen gene essentiality during polymicrobial infection.A post-planktonic era of in vitro infectious models: issues and changes addressed by a clinically relevant wound like media.All together now: experimental multispecies biofilm model systems.The presence of biofilm structures in atherosclerotic plaques of arteries from legs amputated as a complication of diabetic foot ulcers.Evolution of Bacterial "Frenemies".Antibiofilm Activity and Synergistic Inhibition of Staphylococcus aureus Biofilms by Bactericidal Protein P128 in Combination with AntibioticsEnzymatic degradation of in vitro Staphylococcus aureus biofilms supplemented with human plasmaNitric oxide-releasing polyacrylonitrile disperses biofilms formed by wound-relevant pathogenic bacteria.Combatting bacterial infections by killing persister cells with mitomycin C.Antibiofilm efficacy evaluation of a bioelectric dressing in mono- and multi-species biofilms.Biofilm formation by Staphylococcus aureus isolates from skin and soft tissue infections.Method to quantify live and dead cells in multi-species oral biofilm by real-time PCR with propidium monoazide.Growth of MRSA and Pseudomonas aeruginosa in a fine-celled foam model containing sessile commensal skin bacteria.Testing wound dressings using an in vitro wound model.Effects of biofilm treatments on the multi-species Lubbock chronic wound biofilm model.Biofilm inhibitory and eradicating activity of wound care products against Staphylococcus aureus and Staphylococcus epidermidis biofilms in an in vitro chronic wound model.Infection mechanism of biofilm-forming Staphylococcus aureus on indwelling foreign materials in mice.Influence of Excipients on the Antimicrobial Activity of Tobramycin Against Pseudomonas aeruginosa Biofilms.Efficacy of hyperbaric oxygen therapy in bacterial biofilm eradication.Blow fly Lucilia sericata nuclease digests DNA associated with wound slough/eschar and with Pseudomonas aeruginosa biofilm.Binding of two bacterial biofilms to dialkyl carbamoyl chloride (DACC)-coated dressings in vitro.
P2860
Q27000973-3C9D99F1-B7A4-42F2-9844-EBBBF43907FEQ28743127-50021855-88E8-4708-9C2B-2DF54CC191A0Q33696629-698A2768-471D-4F46-B0CD-9C14364B13B5Q34384619-1CAA901B-15D6-4382-A97E-633FE4DDAA10Q34524371-4C2EB8F9-92FA-4211-BE40-54B53C5330AFQ34545294-238749EE-B4C7-46F2-882F-9E362A902E79Q34596119-164F09DC-9184-4E71-8ED7-F76EE92A2765Q35004955-27C23076-7CEF-4DDC-9530-7100F959631DQ35666253-36AF4856-594B-4D99-B9CF-C8540B9CF642Q35666609-F70CFCE7-BEF1-46B3-81B3-A0C368C2A1C2Q35848074-14CFF429-1822-4537-82B2-E1C8AFACEEA3Q35865920-0CC3D0EC-51B4-4384-8658-CCE71062AB66Q36977156-DD3A20FB-9ABB-41AB-9631-B9BE940ACD04Q37340283-08B65390-2710-4CCD-8205-CD6297786F1FQ37471874-E5A252EC-8EA6-44D2-BFEB-9A20486A6977Q38044030-7095A9F7-682B-4EB3-AC04-E935E36C959BQ38265634-E510D195-A1D5-47C9-895E-9FE32E481609Q38378865-658B0E09-9D79-4CBB-899F-9C4EEEB0C8D1Q38613325-A2291D61-5D27-4C36-BD4B-F438DF72458BQ38757686-E07E76FD-EF17-4F4E-86C2-396B3ADF682FQ39015190-DBB20AFC-D12F-4949-9884-9FBA01C33795Q39017878-7EB6A551-CF0B-48D3-9619-052ED48E381CQ39136266-8799E2EC-CDA6-437C-8B95-E1610D3FCA94Q40201613-BFD9C4ED-C985-4B77-93A4-D29EB8F8ED56Q40526792-9959BD08-B664-4B50-93A5-41E950C6C572Q40676215-A74DF53D-CB03-4CDA-98E9-FB792FFDB95BQ40827021-0B6BD245-10C3-452D-851F-0AA85C78561BQ41347787-BF3618B7-4C69-4F3C-AF31-A0E66967A34AQ41486031-676DFCE8-B89E-4AD9-8C72-FD635BA08325Q41546529-E3F94772-6913-4B39-9E76-F898EC6E284EQ41812332-E01282F1-06E8-495C-ACDB-463541672B3DQ41852715-66EA17B7-E83A-43E8-B29F-661964463983Q42112552-A39D0A6D-D683-41E2-9616-FD16B1D894DFQ43191642-DF22DA1E-E698-4F09-B0D5-07B03732E014Q45889513-05E6E366-5FF8-4245-B4B8-AD4A660E54F2Q46224785-899C3AD0-19B5-453E-8D4A-C4810718BF76Q47755759-7B775EC7-D08E-45F7-8AEE-04FF80E1DA1FQ48537834-1F256572-36C5-49A7-8637-9A51B080BE60Q50493107-20248A32-5DC6-4B25-9CDF-FAAA38F04AEDQ51522640-4AD6DC8F-C8D1-4AC6-ABE8-9DDDC8BBFB2D
P2860
In vitro multispecies Lubbock chronic wound biofilm model.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
In vitro multispecies Lubbock chronic wound biofilm model.
@en
type
label
In vitro multispecies Lubbock chronic wound biofilm model.
@en
prefLabel
In vitro multispecies Lubbock chronic wound biofilm model.
@en
P2093
P2860
P1476
In vitro multispecies Lubbock chronic wound biofilm model
@en
P2093
Ethan Smith
Randall D Wolcott
P2860
P304
P356
10.1111/J.1524-475X.2008.00434.X
P577
2008-11-01T00:00:00Z